Netflix can sustain its lofty valuation only if global subscriber growth can support increasing content spending and debt.Technologyread more
The company blamed its Q2 content slate and price increases for the subscriber miss.Technologyread more
IBM's year-over-year revenue has now declined for four quarters in a row. Impact from Red Hat is not yet factored into the company's guidance.Technologyread more
The House voted to table a resolution to start impeachment proceedings against President Donald Trump introduced by Rep. Al Green.Politicsread more
See which stocks are posting big moves after the bell on July 17.Market Insiderread more
Silicon Valley workers say they gravitate toward Yang, who is running for president as a Democrat, because of his approach to research and understanding of tech's moral...Technologyread more
Prosecutors in Masschusetts have dropped a criminal case against actor Kevin Spacey, who had been accused of groping an 18-year-old man.Entertainmentread more
"The passport contains numerous ingress and egress stamps, including stamps that reflect use of the passport to enter France, Spain, the United Kingdom, and Saudi Arabia in...Politicsread more
Loup Ventures founder Gene Munster told CNBC's "Fast Money" on Wednesday that Netflix's disappointing second quarter results are a turning point for the company, saying the...Technologyread more
Corporate earnings forecasts for the second quarter were lowered so much that companies are easily beating them.Market Insiderread more
The central bank is not normally in the business of easing into an economy that is showing few signs of a recession, generally holding fire until more pronounced signs of a...The Fedread more
President Donald Trump on Tuesday was expected to sign an executive order meant to streamline regulations and cut costs associated with biotechnology, the White House announced.
The order would pressure international trading partners — including China — to lift barriers in the biotech industry, which creates products such as pesticides and genetically engineered plants bred to resist diseases, three sources told CNBC.
Officials from the White House and relevant agencies — the Department of Agriculture, the Food and Drug Administration and the Environmental Protection Agency — briefed affected companies on a call earlier Tuesday, according to three participants.
The order was viewed as a way to bolster the bottom line of farmers caught in the crosshairs of Trump's trade war with China, the sources said.
Officials stressed the need for domestic and international rules to be standardized to avoid disrupting trade and to allow quicker approvals for products developed in the U.S. but sold overseas, the participants said.
U.S. soybean farmers in particular are affected by regulations that keep them from selling genetically modified products in some international markets, including China, Brazil and the European Union, without certain clearances.
A factsheet released by the White House said securing regulatory approvals for genetically engineered agricultural products can take up to a decade.
The order "will help eliminate delays, reduce developer costs, and provide greater certainty about the review process for farmers," the White House said in the release.
The announcement was released as Trump spoke at a rally in Iowa, where he criticized China on trade and touted his support for farmers.